Prophylaxis against disseminated Mycobacterium avium complex in AIDS

Journal of Infection

Volumn 38, Issue 1, 1999, Pages 6-8

  Ong, E L C ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHEMOPROPHYLAXIS; HUMAN; INFECTION PREVENTION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; SHORT SURVEY;

EID: 0033031262     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90019-1     Document Type: Review

References (19)

1. Jacobson M, Hopewell P, Yajko D et al. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991; 164: 994-998.
2. Chaisson R, Moore R, Richman D et al. Incidence and natural history of Mycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am Rev Respir Dis 1992; 146: 285-289.
3. Okell DO, Sewankambo N, Goodgame R et al. Absence of bacteriamia with Mycobacterium aviam - intracellulare in ganda patients with AIDS. J Infect Dis 1990; 162: 208-210.
4. Horsburg CR, Selik RM. The epidemiology of disseminated nontuberculosis mycobacterial infections in the acquired immunodeliciency syndrome [AIDS]. Am Rev Respir Dis 1989; 139: 4-7.
5. Hoover DR, Graham NMH, Bacellar H et al. An epidemiologic analysis of Mycobacterium avium complex disease in homesexual men infected with human immunodeficiency virus Type J. Clin Infect Dis 1995; 20: 1250-1258.
6. Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA, Opportunist mycobacteria in England and Walse: 1982 to 1994. CDR 1996; 6: R147-R151.
7. Nightingalse SD, Cameron DW, Gordin FM et al. Two controlled trial of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993; 329: 828-833.
8. Pierce M, Crampton S, Henr D et al. A randomised trial of clarithromycin as prophylaxis against disseminated Mycobocterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996; 335: 392-398.
9. Havlir DV, Dube MP, Sattler FR et al. Prophylaxis against disseminated mycobacterium avium complex with weekly azithromycin. daily rifabutin or both. N. Engl J Med 1996; 335: 392-398.
10. Moore RD, Chaisson RE. Survival analysis of two controlled trials of rifabufin prophylaxis against mycobacterium avium complex infection in AIDS. AIDS 1995; 9: 1337-1342.
11. Oldfield EC, Dickinson G, Chung R et al. Once weekly azithromycin for the prevention of Mycobacterium avium complex in AIDS patients. In: Abstracts of the Third Conference on Retroviruses and Opportunistic Infections. Washington DC. January 28-February 1 1996. American Society for Microbiology 1996: 90 (abstract).
12. Benson CA, Cohn DL, Williams P et al. A phase III prospective randomised double blind study of the safety and efficacy of clarithromycin (CLA) vs rifabutin (RBT) vs CLA + RBT for the prevention of Mycobacterium avium complex disease in HIV + patients with CD4 counts <100 cells per cu mm. In: Abstracts of the Third Conference on Retroviruses and Opportunistic Infections. Washington DC, January 28-February 1 1996 Washington DC, U.S.A. American Society for Microbiology 1996: 91 (abstract).
13. Datri 001 Study Group. Clarithromycin plus rifabutin for MAC prophylaxis: evidence for a drug interaction. In: Abstracts of the First National Conference on Human Retroviruses, Washington DC, December 12-14, 1998. American Society for Microbiology 1993: 106 (abstract).
14. Kaplan JE, Masur H, Holmes KK et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin Infect Dis 1995; 21 (Suppl. 12): S12-S31.
15. Ostroff SM, Speigel RA, Feinberg J, Benson CA, Horsburgh CR. Preventing disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995: 21 (Suppl.): S72-S76.
16. Allen C, Canaugh JH, Shi H, Hu A, Granneman GR, Leonard J. Assessment of multiple doses of ritonavir on the pharmacokineties of rifabutin. Presented at the 11th International Conference on AIDS. Vancouver BC. July 7-12 1996 (abstract).
17. The Indinavir Pharmacokinetic Study Group, Indinavir (MK639) drug interaction studies. Presented at the 11th International Conference on AIDS, Vancouver BC, July 7-12 1996 (abstract).
18. Shafran SD, Singer J, Zarowhy DP et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteriamia in AIDS: rifabutin, ethambutol and clarithromycin versus rifampin. ethambutol. clofazimine and ciprolloxacin. N Engl J Med 1996; 335: 377-383.
19. Fallon J, Owen C, Metcalf J, Fyfe G, Lane HC. NIAID-Clinical Center AIDS Program. Indinavir and interleukin-2 in HIV: one year follow-up [abstract no 1108]. In: Program and abstracts of the 3rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans), Washington, DC, American Society for Microbiology. 1996.